Expression of immunoregulatory molecules by thyrocytes protects nonobese diabetic-H2h4 mice from developing autoimmune thyroiditis

Endocrinology

Volumn 150, Issue 3, 2009, Pages 1545-1551

  Nakahara, Mami ^a   Nagayama, Yuji ^a   Saitoh, Ohki ^a   Sogawa, Rintaro ^a   Tone, Shigenobu ^b   Abiru, Norio ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CD47 ANTIGEN; GELATINASE A; GLUCOSE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN TYROSINE PHOSPHATASE SHP; SOMATOMEDIN C; SRC HOMOLOGY 2 DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE SUBTRATE 1; UNCLASSIFIED DRUG; CYTOKINE; IMMUNOLOGIC FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXPOSURE; HYPERGLYCEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SWINE; VASCULAR SMOOTH MUSCLE; ADENOVIRUS; ANIMAL; ANTIBODY SPECIFICITY; AUTOIMMUNE THYROIDITIS; BLOOD; CELL PROTECTION; CELL STRAIN COS1; CERCOPITHECUS; CYTOLOGY; EVALUATION; FEMALE; GENE THERAPY; GENETICS; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; MOUSE; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; THYROID GLAND;

ADENOVIRIDAE; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOKINES; CYTOPROTECTION; FEMALE; GENE THERAPY; IMMUNOLOGIC FACTORS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MALE; MICE; MICE, INBRED NOD; ORGAN SPECIFICITY; T-LYMPHOCYTES, REGULATORY; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 62749143520     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0702     Document Type: Article

References (33)

1. Wiley SR, Schooley K, Smolak PJ, Din SW, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG 1995 Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682
2. Mellor AL, Munn DH 2004 IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762-774
3. Hirata S, Senju S, Matsuyoshi H, Fukuma D, Uemura Y, Nishimura Y 2005 Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. J Immunol 174:1888-1897
4. Hirata S, Matsuyoshi H, Fukuma D, Kurisaki A, Uemura Y, Nishimura Y, Senju S 2007 Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein peptide plus TRAIL. J Immunol 178:918-925
5. -/-mice. Nat Immunol 4:255-260
6. Song K, Chen Y, Göke R, Wilmen A, Seidel C, Göke A, Hilliard B, Chen Y 2000 Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 191:1095-1104
7. Sato K, Nakaoka T, Yamashita N, Yagita H, Kawasaki H, Morimoto C, Baba M, Matsuyama T 2005 TRAIL-transduced dendritic cells protect mice from acute graft-versus-host disease and leukemia relapse. J Immunol 174:4025-4033
8. Munn D, Zhou M, Attwood J, Bondarev I, Conway S, Marshall B, Brown C, Mellor A 1998 Prevention of allogenic fetal rejection by tryptophan catabolism. Science 281:1191-1193
9. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL 1999 Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363-1372
10. Sakurai K, Zou J, Tschetter J, Ward J, Sheearer G 2002 Effect of indoleamine 2,3-dioxygenase on inhibition of experimental autoimmune encephalomyelitis. J Neuroimmunol 129:186-196
11. Gurtner GJ, Newberry RD, Schloemann SR, McDonald KG, Stenson WF 2003 Inhibition of indoleamine 2,3 dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 125:1762-1773
12. Alexander AM, Crawford M, Bertera S, Rudert WA, Takikawa O, Robbins PD, Trucco M 2002 Indoleamine 2, 3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 51:356-365
13. + cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am J Respir Cell Mol Biol 30:311-318
14. Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ 2003 Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9:1269-1274
15. h4 mice. Clin Immunol Immunopathol 81:287-292
16. ++ nonobese diabetic mice develop insulitis and diabetes. J Exp Med 178:793-803
17. Braley-Mullen H, Sharp GC, Medling B, Tang H 1999 Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Autoimmun 12:157-165
18. Nagayama Y, Kita-Furuyama M, Nakao K, Ando T, MizuguchiH, Hayakawa T, Eguchi K, Niwa M 2002 A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing thyrotropin receptor. J Immunol 168:2789-2794
19. Nagayama Y, Mizuguchi H, Hayakawa T, Niwa M, McLachlan SM, Rapoport B 2003 Prevention of autoantibody-mediated Graves'-like hyperthy-I roidism in mice by IL-4, a Th2 cytokine. J Immunol 170:3522-3527
20. Ahn SH, Henderson Y, Kang Y, Chattopadhyay C, Holton P, Wang M, Briggs K, Clayman GL 2008 An orthotopic model of papillary thyroid carcinoma in athymic mice. Arch Otolaryngol Head Neck Surg 134:190-197
21. Jeker LT, Hejazi M, Burek CL, Rose NR, Caturegli P 1999 Mouse thyroid primary culture. Biochem Biophys Res Commun 257:511-515
22. Suzuki S, Tone S, Takikawa O, Kubo T, Kohno I, Minatogawa Y 2001 Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepti. Biochem J 355(Pt 2):425-429
23. h4 mice. J Autoimmun 29:195-202
24. + regulatory T cells in the islets in no-obese diabetic mice. Biochem Biophys Res Commun 367:719-724
25. + regulatory T cells in normal and tumor-bearing mice. Int Immunopharmacol 4:1785-1793
26. Fallarino F, GrohmanU,You S,McGrath BC, Cavener DR,Vacca C, Orabona C, Bianchi R, Belladonna ML, Volpi C, Fioretti MC, Puccetti P 2006 Tryptophan catabolism generates autoimmune-preventive regulatory T cells. Transpl Immunol 17:58-60
27. + regulatory T cells: thymus or periphery. J Clin Invest 112:1310-1312
28. Mizuguchi H, Koizumi N, Hosono T, Utoguchi N, Watanabe Y, Kay MA, Hayakawa T 2001 A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther 8:730-735
29. Bateux F, Trebeden H, Charrerie J, Chiocchia G 1999 Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding interleukin-10. Eur J Immunol 29:958-963
30. Bateux F, Tourneur L, Trebeden H, Charreire J, Chiocchia G 1999 Gene therapy of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for Fas ligand. J Immunol 162:603-608
31. Yao Q, Wang S, Gambotto A, Glorioso JC, Evans CH, Robbins PD, Ghivizzani SC, Oligino TJ 2003 Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium. Gene Ther 10:1055-1060
32. Wang SH, Cao Z, Wolf JM, Antwerp V, Baker Jr JR 2005 Death ligand tumor necrosis factor related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis. Endocrinology 146:4721-4726
33. low regulatory T cell. Thyroid 17(Suppl l):S-77